John C. Rotschafer - Publications, H-index & Citations

John C. Rotschafer

University of Illinois System

35H指数

161论文数

7.5K被引数

收录论文 21

发表时间

Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

CLINICAL INFECTIOUS DISEASES

IF7.3

2020-07-13

303

OAAI

Rybak, Michael J.; Le, Jennifer; Lodise, Thomas P.; Levine, Donald P.; Bradley, John S.; Liu, Catherine; Mueller, Bruce A.; Pai, Manjunath P.; Wong-Beringer, Annie; Rotschafer, John C.; Rodvold, Keith A.; Maples, Holly D.; Lomaestro, Benjamin

Discrepancy in Vancomycin AUC/MIC Ratio Targeted Attainment Based upon the Susceptibility Testing in Staphylococcus aureus 基于金黄色葡萄球菌药敏试验的万古霉素AUC/MIC比值目标达标率差异

ANTIBIOTICS-BASEL

IF4.6

2016-09-27

OAAI

Eum, Seenae; Bergsbaken, Robert L.; Harvey, Craig L.; Warren, J. Bryan; Rotschafer, John C.

Microbiological Assessment of Polymyxin B Components Tested Alone and in Combination

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2015-12-01

OAAI

Kassamali, Zahra; Prince, Randall A.; Danziger, Larry H.; Rotschafer, John C.; Rhomberg, Paul R.; Jones, Ronald N.

CLOSTRIDIUM-DIFFICILE COLONIZATION IN RESIDENTS OF LONG-TERM-CARE FACILITIES - PREVALENCE AND RISK-FACTORS

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

IF4.5

2015-04-27

PREAI

WALKER, KJ; GILLILAND, SS; VANCEBRYAN, K; MOODY, JA; LARSSON, AJ; ROTSCHAFER, JC; GUAY, DRP

The Urgent Need for Clear and Accurate Information on the Polymyxins Reply

CLINICAL INFECTIOUS DISEASES

IF7.3

2013-08-09

OAAI

Kassamali, Zahra; Rotschafer, John C.; Jones, Ronald N.; Prince, Randall A.; Danziger, Larry H.

Polymyxins: Wisdom Does Not Always Come With Age

CLINICAL INFECTIOUS DISEASES

IF7.3

2013-05-31

OAAI

Kassamali, Zahra; Rotschafer, John C.; Jones, Ronald N.; Prince, Randall A.; Danziger, Larry H.

Optimal Use of Fluoroquinolones in the Intensive Care Unit Setting

CRITICAL CARE CLINICS

IF2.4

2011-01-01

OAAI

Rotschafer, John C.; Ullman, Mary A.; Sullivan, Christopher J.

Continuous Infusion of Vancomycin Less Effective and Safe than Intermittent Infusion, Based on Pharmacodynamic and Pharmacokinetic Principles Reply

CLINICAL INFECTIOUS DISEASES

IF7.3

2009-12-15

OAAI

Rybak, Michael J.; Lomaestro, Ben; Rotschafer, John; Moellering, Robert C., Jr.; Levine, Donald P.

Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2005-02-01

OAAI

Hermsen, ED; Hovde, LB; Sprandel, KA; Rodvold, KA; Rotschafer, JC

Dynamic analysis of peritoneal dialysis associated peritonitis

ASAIO JOURNAL

IF2.3

2004-11-01

OAAI

Hotchkiss, JR; Hermsen, ED; Hovde, LB; Simonson, DA; Rotschafer, JC; Crooke, PS

The importance of bactericidal drugs: Future directions in infectious disease

CLINICAL INFECTIOUS DISEASES

IF7.3

2004-11-01

175

OAAI

Finberg, RW; Moellering, RC; Tally, FP; Craig, WA; Pankey, GA; Dellinger, EP; West, MA; Joshi, M; Linden, PK; Rolston, KV; Rotschafer, JC; Rybak, MJ

Role of topoisomerase mutations and efflux in fluoroquinolone resistance of Bacteroides fragilis clinical isolates and laboratory mutants

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2004-04-01

OAAI

Ricci, V; Peterson, ML; Rotschafer, JC; Wexler, H; Piddock, LJV

Polymyxins: Pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

IF4.1

2003-09-01

PREAI

Hermsen, ED; Sullivan, CJ; Rotschafer, JC

Comparison of linezolid activities under aerobic and anaerobic conditions against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2003-01-01

OAAI

Gunderson, BW; Ibrahim, KH; Peloquin, CA; Hovde, LB; Rotschafer, JC

Comparative pharmacodynamics of three newer fluoroquinolones versus six strains of staphylococci in an in vitro model under aerobic and anaerobic conditions

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2002-05-01

OAAI

Wright, DH; Gunderson, BW; Hovde, LB; Ross, GH; Ibrahim, KH; Rotschafer, JC

Pharmaco dynamics of trovafloxacin and levofloxacin against Bacteroides fragilis in an in vitro pharmacodynamic model

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2002-01-01

OAAI

Peterson, ML; Hovde, LB; Wright, DH; Brown, GH; Hoang, AD; Rotschafer, JC

Fluoroquinolone resistance in anaerobic bacteria following exposure to levofloxacin, trovafloxacin, and sparfloxacin in an in vitro pharmacodynamic model

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2001-07-01

OAAI

Ross, GH; Wright, DH; Hovde, LB; Peterson, ML; Rotschafer, JC

Editorial response: Single daily dosing of aminoglycosides - A community standard?

CLINICAL INFECTIOUS DISEASES

IF7.3

2000-03-01

PREAI

Brown, GH; Bertino, JS; Rotschafer, JC

Decreased in vitro fluoroquinolone concentrations after admixture with an enteral feeding formulation

JOURNAL OF PARENTERAL AND ENTERAL NUTRITION

IF4.1

2000-01-01

PREAI

Wright, DH; Pietz, SL; Konstantinides, FN; Rotschafer, JC

Fluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposure

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

1999-09-01

OAAI

Peterson, ML; Hovde, LB; Wright, DH; Hoang, AD; Raddatz, JK; Boysen, PJ; Rotschafer, JC

研究方向